Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Principles of antibody therapy.

S J Russell1, M B Llewelyn, R E Hawkins

  • 1MRC Centre, Cambridge.

BMJ (Clinical Research Ed.)
|December 5, 1992
PubMed
Summary

Monoclonal antibodies offer targeted therapies with fewer side effects. Advances in antibody design and engineering are expanding their use in treating various conditions, from transplant rejection to cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PIWIs, piRNAs and Retrotransposons: Complex battles during reprogramming in gametes and early embryos.

Reproduction in domestic animals = Zuchthygiene·2017
Same author

High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.

Blood cancer journal·2017
Same author

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains.

Leukemia·2017
Same author

Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial.

Leukemia·2017
Same author

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma.

Blood cancer journal·2017
Same author

Natural history of t(11;14) multiple myeloma.

Leukemia·2017

Area of Science:

  • Immunology
  • Biotechnology
  • Pharmacology

Background:

  • Monoclonal antibodies (mAbs) are crucial in modern medicine, but their success hinges on effective design.
  • Target selection is paramount, as antibody properties can be genetically modified.
  • Current applications include immunosuppression and potential treatments for infections and cancers.

Purpose of the Study:

  • To review the design principles and clinical applications of monoclonal antibodies.
  • To highlight the expanding role of antibody engineering in therapeutic development.
  • To discuss the challenges and future prospects of monoclonal antibodies in medicine.

Main Methods:

  • Review of existing literature on monoclonal antibody design and clinical trials.
  • Analysis of therapeutic successes and limitations in various disease areas.
  • Discussion of emerging trends in antibody engineering and target identification.

Main Results:

  • Monoclonal antibodies targeting lymphocyte antigens provide less toxic immunosuppression, exemplified by their use in renal transplant rejection.
  • Clinical trials for septic shock and development for pathogens like herpes simplex virus are underway.
  • While cancer treatment faces challenges due to tumor penetration, blood cancer therapies show promise, with human antibodies against B cell malignancies in clinical testing.

Conclusions:

  • Effective monoclonal antibody design is essential for clinical success.
  • Targeting lymphocyte antigens offers a promising avenue for less toxic immunosuppression.
  • Continued advancements in antibody engineering and a deeper understanding of immune responses will likely increase the clinical utility of monoclonal antibodies across diverse diseases.

Related Experiment Videos